Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis

AASLD guidelines for the treatment of hepatocellular carcinoma

(2017) Julie K. Heimbach et al.   HEPATOLOGY

Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion

(2016) Takashi Kokudo et al.   JOURNAL OF HEPATOLOGY

Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area

(2016) Jung Ho Im et al.   LIVER INTERNATIONAL

A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib

(2016) Manuel A. de la Torre et al.   LIVER INTERNATIONAL

Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis

(2015) Julien Edeline et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Personalized Dosimetry with Intensification Using 90Y-Loaded Glass Microsphere Radioembolization Induces Prolonged Overall Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis

(2015) E. Garin et al.   JOURNAL OF NUCLEAR MEDICINE

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

LI-RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI-RADS Management Working Group and future directions

(2014) Donald G. Mitchell et al.   HEPATOLOGY

Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis

(2014) Takashi Kokudo et al.   JOURNAL OF HEPATOLOGY

Safety of Liver Resection for Hepatocellular Carcinoma After Sorafenib Therapy: A Multicenter Case-Matched Study

(2013) Louise Barbier et al.   ANNALS OF SURGICAL ONCOLOGY

Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus

(2012) Zhen-Wei Peng et al.   CANCER

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial

(2012) Ann-Lii Cheng et al.   EUROPEAN JOURNAL OF CANCER

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

(2012) Jordi Bruix et al.   JOURNAL OF HEPATOLOGY

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection

(2012) Rumi Matono et al.   HPB

A new classification for hepatocellular carcinoma with portal vein tumor thrombus

(2010) Jie Shi et al.   Journal of Hepato-Biliary-Pancreatic Sciences